Standardized Production of Anti‐Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research
Current Protocols · 2024
DOI: 10.1002/cpz1.1118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Eliane J Mueller und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department for Biomedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Pemphigus, Desmoglein 3. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Antibody‐mediated receptor activation is successfully used to develop medical treatments. If the activation induces a pathological response, such antibodies are also excellent tools for defining molecular mechanisms of target receptor malfunction and designing rescue therapies. Prominent examples are naturally occurring autoantibodies inducing the severe blistering disease pemphigus vulgaris (PV). In the great majority of patients, the antibodies bind to the adhesion receptor desmoglein 3 (Dsg3) and interfere with cell signaling to provoke severe blistering in the mucous membranes and/or skin. The identification of a comprehensive causative signaling network downstream of antibody‐targeted Dsg3 receptors (e.g., shown by pharmacological activators or inhibitors) is currently being discussed as a basis to develop urgently needed first‐line treatments for PV patients. Although polyclonal PV IgG antibodies have been used as proof of principle for pathological signal activation, monospecific anti‐Dsg3 antibodies are necessary and have been developed to identify pathological Dsg3 receptor–mediated signal transduction. The experimental monospecific PV antibody AK23, produced from hybridoma cells, was extensively tested in our laboratory in both in vitro and in vivo models for PV and proved to recapitulate the clinicopathological features of PV when generated using the standardized production and purification protocols described herein. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. This article was corrected on 18 November 2025. See the end of the full text for details. Basic Protocol 1 : Bovine IgG stripping from FBS and quality control Basic Protocol 2 : AK23 hybridoma expansion and IgG production Basic Protocol 3 : AK23 IgG purification Basic Protocol 4 : AK23 IgG quality control Support Protocol 1 : Detection of endotoxin levels Support Protocol 2 : Detection and removal of mycoplasma
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Biomedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland.
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
- Protein Production and Structure Core Facility, School of Life Sciences, EPFL Lausanne, Lausanne, Switzerland.
- CSL, CSL Biologics Research Centre, Bern, Switzerland.
- Swiss Institute for Translational and Entrepreneurial Medicine, sitem-insel, Bern, Switzerland.
ORCID-Profile: Siavash Rahimi, William V J Hariton
Zitieren
APA
Mueller, E. J., Rahimi, S., Sauta, P., Shojaeian, T., Durrer, L., Quinche, S., Francois, M., Locher, E., Edler, M., Illi, M., Gentinetta, T., Lau, K., Pojer, F., Borradori, L., & Hariton, W. V. J. (2024). Standardized Production of Anti‐Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research. Current Protocols. https://doi.org/10.1002/cpz1.1118
Vancouver
Mueller EJ, Rahimi S, Sauta P, Shojaeian T, Durrer L, Quinche S, et al. Standardized Production of Anti‐Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research. Current Protocols. 2024. doi:10.1002/cpz1.1118
BibTeX
@article{Mueller2024,
author = {Mueller, Eliane J and Rahimi, Siavash and Sauta, Patrizia and Shojaeian, Taravat and Durrer, Laurence and Quinche, Soraya and Francois, Michael and Locher, Elisabeth and Edler, Monika and Illi, Marlies and Gentinetta, Thomas and Lau, Kelvin and Pojer, Florence and Borradori, Luca and Hariton, William V J},
title = {Standardized Production of Anti‐Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research},
journal = {Current Protocols},
year = {2024},
doi = {10.1002/cpz1.1118}
}
EUVIMED